XML 13 R5.htm IDEA: XBRL DOCUMENT v3.24.0.1
STATEMENT OF STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
Total
Cumulative Effect, Period of Adoption, Adjustment [Member]
Cumulative Effect, Period of Adoption, Adjusted Balance [Member]
Private Placement
Public Offering
Global Ichiban Convertible Note
Nanyang Convertible Notes
Fleur
L1 Convertible Note
Sabby Note
Series 1B Preferred Stock
Preferred Stock
Series A Preferred Stock
Preferred Stock
Series A Preferred Stock
Cumulative Effect, Period of Adoption, Adjusted Balance [Member]
Preferred Stock
Series 1A Preferred Stock
Preferred Stock
Series 1A Preferred Stock
TubeSolar
Preferred Stock
Series 1A Preferred Stock
Crowdex Convertible Notes
Preferred Stock
Series 1B Preferred Stock
Common Stock
Common Stock
Cumulative Effect, Period of Adoption, Adjusted Balance [Member]
Common Stock
Private Placement
Common Stock
Public Offering
Common Stock
TubeSolar
Common Stock
Crowdex Convertible Notes
Common Stock
Global Ichiban Convertible Note
Common Stock
Nanyang Convertible Notes
Common Stock
Fleur
Common Stock
L1 Convertible Note
Common Stock
Sabby Note
Additional Paid-In Capital
Additional Paid-In Capital
Cumulative Effect, Period of Adoption, Adjustment [Member]
Additional Paid-In Capital
Cumulative Effect, Period of Adoption, Adjusted Balance [Member]
Additional Paid-In Capital
Private Placement
Additional Paid-In Capital
Public Offering
Additional Paid-In Capital
TubeSolar
Additional Paid-In Capital
Crowdex Convertible Notes
Additional Paid-In Capital
Global Ichiban Convertible Note
Additional Paid-In Capital
Nanyang Convertible Notes
Additional Paid-In Capital
Fleur
Additional Paid-In Capital
L1 Convertible Note
Additional Paid-In Capital
Sabby Note
Accumulated Deficit
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment [Member]
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjusted Balance [Member]
Other Accumulated Comprehensive Loss
Other Accumulated Comprehensive Loss
Cumulative Effect, Period of Adoption, Adjusted Balance [Member]
Beginning balance at Dec. 31, 2021 $ (2,833,606)                     $ 5           $ 12                     $ 424,949,165                       $ (427,782,788)        
Beginning balance (in shares) at Dec. 31, 2021                       48,100   3,700       113,256                                                      
Conversion of shares           $ 7,900,000 $ 1,500,000 $ 1,000,000   $ 107,101                       $ 2 $ 1 $ 8 $ 2 $ 1               $ (2) $ (1) $ 7,899,992 $ 1,499,998 $ 999,999   $ 107,101          
Conversion of shares (in shares)                             (2,400) (1,300)           24,000 13,000 79,000 15,000 10,000   350                                  
Warrants 2,990,029     $ 2,448,595                                                 2,990,029     $ 2,448,595                          
Beneficial conversion feature 4,490,029                                                       4,490,029                                
Proceeds from issuance of Common Stock       2,551,405                                                       2,551,405                          
Proceeds from issuance of Common Stock (in shares)                                       4,717                                                  
Issuance costs       $ (1,276,017)                                                       $ (1,276,017)                          
Share-based compensation 5,478,734                                                       5,478,734                                
Net Loss (19,754,705)                                                                               (19,754,705)        
Foreign Currency Translation Gain/(Loss) (16,024)                                                                                     $ (16,024)  
Ending balance at Dec. 31, 2022 $ 4,585,541 $ (3,686,243) $ 899,298                 $ 5 $ 5         $ 26 $ 26                   452,139,027 $ (3,795,874) $ 448,343,153                   (447,537,493) $ 109,631 $ (447,427,862) (16,024) $ (16,024)
Ending balance (in shares) at Dec. 31, 2022                       48,100 48,100         259,323 259,323                                                    
Accounting Standards Update [Extensible Enumeration] Accounting Standards Update 2020-06 [Member]                                                                                        
Conversion of shares $ 6,990,269               $ 806,802 $ 2,275,598                                 $ 33 $ 13                     $ 806,769 $ 2,275,585          
Conversion of shares (in shares)                                                     328,502 137,072                                  
Warrants         $ 4,627,737                                                       $ 4,627,737                        
Proceeds from issuance of Series 1B Preferred Stock 900,000                                                       900,000                                
Proceeds from issuance of Series 1B Preferred Stock (in shares)                     900                                                                    
Proceeds from issuance of Common Stock         616,514                               $ 39                       616,475                        
Proceeds from issuance of Common Stock (in shares)                                         389,024                                                
Common stock issued for services 92,750                                                       92,750                                
Common stock issued for services (in shares)                                   1,425                                                      
Prefunded warrants         5,044,977                                                       5,044,977                        
Issuance costs (20,000)       $ (1,068,796)                                               (20,000)       $ (1,068,796)                        
Down round deemed dividend 17,980,678                                                       17,980,678                       (17,980,678)        
Share-based compensation 2,243,445                                                       2,243,445                                
Repayment of Series 1B Preferred Stock $ (900,000)                                                       (900,000)                                
Repayment of Series 1B Preferred Stock (in shares)                                 (900)                                                        
Conversion of prefunded warrants                                   $ 247                     (247)                                
Conversion of prefunded warrants (in shares) 2,468,500                                 2,468,500                                                      
Net Loss $ (17,069,896)                                                                               (17,069,896)        
Foreign Currency Translation Gain/(Loss) 24,960                                                                                     24,960  
Ending balance at Dec. 31, 2023 $ (1,526,611)                     $ 5           $ 358                     $ 480,942,526                       $ (482,478,436)     $ 8,936  
Ending balance (in shares) at Dec. 31, 2023                       48,100           3,583,846